🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, physicians and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the service has taken down problematic content and banned related keywords and search suggestions. The company said it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

Within minutes of entering one group, a seller shared contact information, where most transactions occur. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Details and Costs

Within these groups, posts show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant medical dangers”.